Clinical Trials Logo

Clinical Trial Summary

This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.


Clinical Trial Description

Open fracture injuries are highly susceptible to infection and infection-related complications. The current routine treatment for these injuries includes the use of systemic IV antibiotics. However, open fracture injuries often have compromised blood supply, reducing the amount of antibiotic that reaches the target tissue while increasing risk of injury to non-target organs. This trial aims to evaluate the effectiveness of early application of a topical vancomycin antibiotic powder on open fracture wounds, in combination with the usual treatment, in reducing the risk of infection seen in these injuries. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03765567
Study type Interventional
Source The University of Texas Health Science Center at San Antonio
Contact Robert A De Lorenzo, MD
Phone 210-567-0056
Email DeLorenzo@uthscsa.edu
Status Recruiting
Phase Phase 4
Start date October 5, 2020
Completion date June 2025

See also
  Status Clinical Trial Phase
Completed NCT01496014 - Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
Not yet recruiting NCT02948387 - Preventing Infections in Orthopaedic Patients N/A
Recruiting NCT06033534 - Evaluation of STIMULAN Device and AI Model in Preventing Fracture Infections N/A
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Recruiting NCT05785182 - OCT in Open Fracture and Infected Fracture
Completed NCT00299052 - Efficacy of DBM on Fractures of the Shinbone (Tibia) Phase 4
Terminated NCT03560232 - Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens Phase 4